Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 Aug 10:15:730378.
doi: 10.3389/fnins.2021.730378. eCollection 2021.

Editorial: Brain Insulin Resistance in Neurodevelopmental and Neurodegenerative Disorders: Mind the Gap!

Mara Dierssen  1   2   3   4 , Eugenio Barone  5
Affiliations
Editorial

Editorial: Brain Insulin Resistance in Neurodevelopmental and Neurodegenerative Disorders: Mind the Gap!

Mara Dierssen et al. Front Neurosci. .
No abstract available

Keywords: Alzheimer's disease; Down syndrome; Parkinson's disease; brain insulin resistance; insulin resistance; learning and memory; neurodegenerative diseases; neurodevelopment and brain metabolism.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Comment on

  • Editorial on the Research Topic Brain Insulin Resistance in Neurodevelopmental and Neurodegenerative Disorders: Mind the Gap!

References

    1. Arnold S. E., Arvanitakis Z., Macauley-Rambach S. L., Koenig A. M., Wang H. Y., Ahima R. S., et al. . (2018). Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums. Nat. Rev. Neurol. 14, 168–181. 10.1038/nrneurol.2017.185 - DOI - PMC - PubMed
    1. Barone E., Di Domenico F., Cassano T., Arena A., Tramutola A., Lavecchia M. A., et al. . (2016). Impairment of biliverdin reductase-A promotes brain insulin resistance in Alzheimer disease: a new paradigm. Free Radic. Biol. Med. 91, 127–142. 10.1016/j.freeradbiomed.2015.12.012 - DOI - PubMed
    1. Barone E., Mosser S., Fraering P. C. (2014). Inactivation of brain Cofilin-1 by age, Alzheimer's disease and gamma-secretase. Biochim. Biophys. Acta 1842(12 Pt A), 2500–2509. 10.1016/j.bbadis.2014.10.004 - DOI - PubMed
    1. Barone E., Tramutola A., Triani F., Calcagnini S., Di Domenico F., Ripoli C., et al. . (2019). Biliverdin reductase-a mediates the beneficial effects of intranasal insulin in Alzheimer disease. Mol. Neurobiol. 56, 2922–2943. 10.1007/s12035-018-1231-5 - DOI - PubMed
    1. Bomfim T. R., Forny-Germano L., Sathler L. B., Brito-Moreira J., Houzel J. C., Decker H., et al. . (2012). An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease- associated Abeta oligomers. J Clin Invest. 122, 1339–1353. 10.1172/JCI57256 - DOI - PMC - PubMed

Publication types